1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Forte Biosciences, Inc.

Forte Biosciences, Inc.

FBRX
Forte Biosciences, Inc.US flagNASDAQ Capital Market
18.18
USD
-1.06
- -
252.37MMarket Cap

Income Statement (USD)

APIChat
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
- -
14
21
14
32
37
71
+ Selling, General & Admin
- -
4
8
8
11
15
12
+ Research & Development
- -
10
14
6
22
21
58
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
- -
-14
-21
-14
-32
-37
-71
- Non-Operating (Income) Loss
- -
32
- -
- -
-1
-1
-2
+ Interest Expense, Net
- -
- -
- -
- -
-1
-1
-3
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
1
1
3
+ Other Non-Op (Income) Loss
- -
32
- -
- -
- -
- -
- -
Pretax Income
- -
-46
-22
-14
-31
-35
-68
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
1
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
- -
-46
-22
-14
-31
-35
-69
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
- -
-46
-22
-14
-31
-35
-69
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-46
-22
-14
-31
-35
-69
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
- -
-46
-22
-14
-31
-35
-69
EBIT
- -
-14
-21
-14
-32
-37
-71
EBITDA
- -
-14
-21
-14
-32
-37
-71
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
EBITA
- -
-14
-21
-14
-32
-37
-71
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
1
1
1
3
15
Basic EPS, GAAP
- -
-157.93
-38.85
-19.96
-24.92
-12.17
-4.71
Basic EPS from Cont Ops
- -
-157.93
-38.85
-19.96
-24.92
-12.17
-4.71
Diluted Weighted Avg Shares
- -
- -
1
1
1
3
15
Diluted EPS, GAAP
- -
-157.93
-38.85
-19.96
-24.92
-12.17
-4.71
Diluted EPS from Cont Ops
- -
-157.93
-38.85
-19.96
-24.92
-12.17
-4.71

Balance Sheet (USD)

APIChat
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
- -
60
43
42
38
61
81
+ Cash, Cash Equivalents & STI
- -
59
42
41
37
58
77
+ Cash & Cash Equivalents
- -
59
42
41
12
22
77
+ ST Investments
- -
- -
- -
- -
25
36
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
1
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
1
+ Inventories
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
- -
- -
1
3
3
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
1
1
- -
1
- -
2
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
1
1
- -
1
- -
2
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
1
1
- -
1
- -
2
Total Assets
- -
61
43
42
39
62
83
+ Payables & Accruals
- -
2
1
2
3
8
19
+ Accounts Payable
- -
1
1
1
1
5
10
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
- -
1
1
3
9
+ ST Debt
- -
- -
- -
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
1
1
1
1
2
2
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
1
1
1
1
2
2
Total Current Liabilities
- -
2
2
3
4
9
21
+ LT Debt
- -
- -
- -
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
1
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
1
Total Noncurrent Liabilities
- -
- -
- -
- -
- -
- -
1
Total Liabilities
- -
2
2
3
4
9
22
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
110
115
126
154
206
284
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
110
115
126
154
206
284
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
- -
-51
-73
-87
-119
-154
-223
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
- -
59
42
39
35
52
61
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
59
42
39
35
52
61
Total Liabilities & Equity
- -
61
43
42
39
62
83
Shares Outstanding
- -
1
1
1
1
6
13
Number of Employees
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
Net Debt
- -
-59
-42
-41
-12
-22
-77
Net Debt to Equity
- -
-99.64
-101.19
-105.88
-33.87
-42.39
-126.18
Tangible Common Equity Ratio
- -
96.31
95.94
92.43
90.6
85.25
73.68
Current Ratio
- -
26.52
24.19
13.06
10.45
6.76
3.88
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
- -
-46
-22
-14
-31
-35
-69
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
32
4
4
3
3
7
+ Stock-Based Compensation
- -
1
4
4
3
3
6
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
1
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
31
- -
- -
- -
- -
- -
+ Chg in Non-Cash Work Cap
- -
-4
1
2
- -
2
11
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
1
- -
-1
-1
-3
+ Inc (Dec) in Accts Payable
- -
-4
-1
1
- -
3
14
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
- -
-18
-17
-8
-29
-31
-51
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
67
- -
7
25
53
75
+ Increase in Capital Stock
- -
67
- -
7
25
53
75
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
-36
36
+ Dec in LT Investment
- -
- -
- -
- -
10
- -
36
+ Inc in LT Investment
- -
- -
- -
- -
-10
-36
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
4
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
4
- -
- -
- -
-36
36
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
- -
- -
- -
- -
-1
-6
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
67
- -
7
25
52
69
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
52
-17
-1
-4
-15
55
EBITDA
- -
-14
-21
-14
-32
-37
-71
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
- -
-18
-17
-8
-29
-31
-51
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-18
-17
-8
-29
-31
-51
Free Cash Flow per Basic Share
- -
-62.59
-29.85
-11.77
-22.8
-10.56
-3.47
Price/Free Cash Flow
- -
-14.54
-1.79
-2.12
-0.91
-2.16
-7.91
Cash Flow to Net Income
- -
0.4
0.77
0.59
0.91
0.87
0.73
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -